login
  Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

St Jude Medical establishes Cardiovascular Division


Thursday, 16 Nov 2006 00:00

St Jude Medical is combining its Cardiac Surgery and Cardiology divisions to create a new Cardiovascular Division, effective 1st January 2007. The Cardiovascular Division will focus on developing and bringing to market medical device technology and services to help patients who suffer from vascular disease or structural heart defects. The Cardiovascular Division will incorporate the activities currently managed by the Cardiac Surgery Division and by the Cardiology Division. The company will continue to have specialised cardiac surgery and cardiology sales forces.

According to Daniel J Starks, chairman, president and CEO of St Jude Medical, the company's cardiology and cardiac surgery businesses will be stronger together than each business is separately. Moreover, he claimed that by streamlining the organisation, the company can boost operating efficiencies and ultimately use the associated savings to invest in research and development.

The new Cardiovascular Division will be led by George J Fazio, who has served as president of St Jude Medical's Cardiac Surgery Division since 2004. Prior to his current role, Fazio was appointed president of St Jude Medical Europe in 2001. His preceding roles included president, Health Care Services for St Jude Medical, and general manager for St Jude Medical's operations in Canada.

Paul R Buckman, currently president of St Jude Medical's Cardiology Division, will become corporate vice president of Business Development. Since joining St Jude Medical in 2004 in his current role, Buckman has overseen a significant expansion of the Cardiology Division's products and programmes. The company is also initiating several changes to enhance the efficiency and effectiveness of its sales and customer service operations in certain international geographies.

As a result of these restructuring plans, St Jude Medical expects to incur a pre-tax charge of US$25 million to US$35 million during the third quarter of 2006. "The creation of a new Cardiovascular Division, together with the expansion of our sales force and recent new product introductions, are part of our comprehensive program to position St Jude Medical to deliver a minimum 15% growth in 2007 and beyond," Starks concluded.



Most popular


First patient enrolled in Vessix sham-controlled study
Friday, 17 Apr 2015
Boston Scientific has announced that it is taking a new approach to evaluate the performance of its Vessix renal Denervation System. It says it is initiating a study with a novel design to isolate ... First patient enrolled in Vessix sham-controlled study

CardioCel to feature at prominent heart valve conferences
Wednesday, 01 Apr 2015
Admedus’ CardioCel will be featured in a number of presentations at the American Association for Thoracic Surgery Mitral Conclave 2015 meeting and the 95th AATS Annual Meeting. CardioCel to feature at prominent heart valve conferences

PICSO system has potential to improve myocardial recovery after PCI
Thursday, 09 Apr 2015
The first safety and feasibility study of pressure-controlled intermittent coronary sinus occlusion (PICSO) in the setting of ST-segment elevation myocardial infarction indicates that the system ... PICSO system has potential to improve myocardial recovery after PCI

Features


Tips and tricks for achieving optimum results with a drug-coated balloon
Thursday, 07 May 2015
With drug-coated balloons, we may have been able to deliver a device to the lesion, but we were not always sure how much drug we actually delivered. Fortunately, because of this problem, there have ... Tips and tricks for achieving optimum results with a drug-coated balloon

Robotic PCI could be used to reduce radiation exposure to the operator
Thursday, 09 Apr 2015
Ryan Madder, an interventional cardiologist at the Frederik Meijer Heart & Vascular Institute (Spectrum Health, Grand Rapids, Michigan, USA) explains why he believes a robotic system (CorPath, C... Robotic PCI could be used to reduce radiation exposure to the operator

Profiles


Flavio Ribichini
Thursday, 05 Mar 2015
Flavio Ribichini speaks to Cardiovascular News about being involved in the first use of primary ... Flavio Ribichini

Sunil Rao
Thursday, 23 Oct 2014
Sunil Rao speaks to Cardiovascular News about his career highlights, including his research into ... Sunil Rao

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions